S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 iCo TherapeuticsAchaogenIntegrated BioPharmaEndonovo TherapeuticsReliv International
SymbolOTCMKTS:ICOTFN/AOTCMKTS:INBPOTCMKTS:ENDVNASDAQ:RELV
Price Information
Current Price$0.09N/A$0.21$0.01$4.43
52 Week RangeN/AHoldN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AHoldN/AN/AN/A
Consensus Price TargetN/A$2.75N/AN/AN/A
% Upside from Price TargetN/A∞ upsideN/AN/AN/A
Trade Information
Market Cap$13.38 million$7.03 million$6.21 million$8.53 million$7.65 million
Beta2.320.78-0.652.470.22
Average Volume27,6883,341,02913,2984,195,9362,214
Sales & Book Value
Annual RevenueN/A$8.73 million$49.98 million$80,000.00$36.12 million
Price / SalesN/A0.000.12106.580.21
CashflowN/AN/A$0.08 per shareN/AN/A
Price / CashN/AN/A2.50N/AN/A
Book Value($0.01) per share($0.13) per share$0.06 per share($0.03) per share$6.50 per share
Price / BookN/A0.003.50-0.330.68
Profitability
Net Income$-1,300,000.00$-186,510,000.00$1.69 million$-6,440,000.00$-1,900,000.00
EPSN/A($3.70)N/AN/AN/A
Trailing P/E Ratio0.00N/A2.630.000.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,136.94%3.39%-8,660.82%-1.27%
Return on Equity (ROE)N/A-357.49%172.11%N/A-3.75%
Return on Assets (ROA)-315.19%-127.68%8.04%-270.24%-2.66%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.00%2.93%N/A0.01%
Current Ratio0.61%0.78%1.14%0.03%1.50%
Quick Ratio0.61%0.77%0.43%0.03%0.89%
Ownership Information
Institutional Ownership PercentageN/A31.85%N/AN/A8.21%
Insider Ownership PercentageN/A7.80%70.70%12.41%31.18%
Miscellaneous
EmployeesN/A206128N/A156
Shares Outstanding150.66 million63.88 million29.57 million852.65 million1.75 million
Next Earnings Date12/5/2019 (Estimated)N/A11/8/2019 (Estimated)11/12/2019 (Estimated)11/8/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
 iCo TherapeuticsAchaogenIntegrated BioPharmaEndonovo TherapeuticsReliv International

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel